Skip to main content
. 2023 Aug 17;16:292–302. doi: 10.1016/j.xjon.2023.07.024

Table 1.

Clinical characteristics

Characteristics (N = 38) Controls (N = 15) MR (N = 14) MR + AF (N = 9) P value
Age, y 66.1 ± 7.8 60.7 ± 9.8 69.0 ± 7.4 .127
Sex, n (%) .193
 Male 5 (33) 9 (64) 7 (78)
 Female 10 (57) 5 (36) 2 (22)
Race, n (%) 1.000
 White 13 (86) 14 (100) 9 (100)
 Black 1 (7) 0 (0) 0 (0)
 Asian 1 (7) 0 (0) 0 (0)
BMI, n (%) 28.2 ± 6.4 28.4 ± 4.6 30.7 ± 5.9 .767
HTN, n (%) 5 (33) 5 (36) 7 (78) .263
DM, n (%) 1 (7) 1 (7) 3 (33) .277
COPD (moderate/severe lung disease), n (%) 1 (7) 0 (0) 1 (11) .422
Previous CVA, n (%) 1 (7) 0 (0) 0 (0) 1.000
Previous MI, n (%) 0 (0) 0 (0) 1 (11) .105
PVD, n (%) 0 (0) 1 (7) 0 (0) 1.000
Smoking history, n (%) 0 (0) 4 (29) 1 (11) .073

P value from one-way analysis of variance for continuous variable and Fisher exact test for categorical variables significant if less than or equal to .05. MR, Mitral regurgitation; AF, atrial fibrillation; BMI, body mass index; HTN, hypertension; DM; diabetes; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular disease; MI, myocardial infarction; PVD, peripheral vascular disease.